INTERCEPT PHARMACEUTICALS, INC. Insider Trading for July 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for July 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Option Exercise | A | 210.36 | 348 | 73,205 | 348 | |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Grant | A | 0.00 | 285 | 0 | 285 | 0 to 285 |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | Patel Sanj K | Director | Option Exercise | A | 210.36 | 551 | 115,908 | 551 | |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | Patel Sanj K | Director | Grant | A | 0.00 | 452 | 0 | 452 | 0 to 452 |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | A | 210.36 | 275 | 57,849 | 275 | |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Grant | A | 0.00 | 226 | 0 | 8,803 | 8.6 K to 8.8 K (+2.63 %) |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | A | 210.36 | 275 | 57,849 | 275 | |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Grant | A | 0.00 | 226 | 0 | 3,530 | 3.3 K to 3.5 K (+6.84 %) |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | Luca Benatti | Director | Option Exercise | A | 210.36 | 551 | 115,908 | 551 | |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | Luca Benatti | Director | Grant | A | 0.00 | 452 | 0 | 492 | 40 to 492 (+1,130.00 %) |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | A | 210.36 | 275 | 57,849 | 275 | |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Grant | A | 0.00 | 226 | 0 | 2,006 | 1.8 K to 2 K (+12.70 %) |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 210.36 | 551 | 115,908 | 551 | |
| Jul 21 2014 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 452 | 0 | 452 | 0 to 452 |
| Jul 18 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 210.36 | 275 | 57,849 | 275 | |
| Jul 18 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 0.00 | 325 | 0 | 324 | |
| Jul 18 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 226 | 0 | 2,818 | 2.6 K to 2.8 K (+8.72 %) |
| Jul 18 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 0.00 | 325 | 0 | 2,592 | 2.3 K to 2.6 K (+14.34 %) |
| Jul 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 391 | 8,407 | 12,589 | |
| Jul 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 222.50 | 158 | 35,155 | 1,780 | 1.9 K to 1.8 K (-8.15 %) |
| Jul 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 216.88 | 233 | 50,533 | 1,938 | 2.2 K to 1.9 K (-10.73 %) |
| Jul 11 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 391 | 8,407 | 2,171 | 1.8 K to 2.2 K (+21.97 %) |
| Jul 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Option Exercise | M | 9.82 | 2,000 | 19,645 | 4,923 | |
| Jul 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Sell | S | 244.00 | 1,000 | 244,000 | 0 | 1,000 to 0 (-100.00 %) |
| Jul 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Sell | S | 242.11 | 1,000 | 242,110 | 1,000 | 2 K to 1,000 (-50.00 %) |
| Jul 09 2014 | ICPT | INTERCEPT PHARMACE ... | TALLARIGO LORENZO | Director | Buy | M | 9.82 | 2,000 | 19,645 | 2,000 | 0 to 2 K |
| Jul 08 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Option Exercise | M | 37.69 | 1 | 38 | 109,999 | |
| Jul 08 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 250.00 | 1 | 250 | 1,410 | 1.4 K to 1.4 K (-0.07 %) |
| Jul 08 2014 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Buy | M | 37.69 | 1 | 38 | 1,411 | 1.4 K to 1.4 K (+0.07 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 7,789 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 14,808 | 13.5 K to 14.8 K (+9.61 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 26,703 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,623 | 0 | 9,735 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 247.65 | 849 | 210,257 | 15,027 | 15.9 K to 15 K (-5.35 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 246.00 | 1,000 | 246,000 | 15,876 | 16.9 K to 15.9 K (-5.93 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 244.75 | 2,000 | 489,499 | 16,876 | 18.9 K to 16.9 K (-10.60 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 241.53 | 1,187 | 286,696 | 18,876 | 20.1 K to 18.9 K (-5.92 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 20,063 | 16.1 K to 20.1 K (+24.90 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,623 | 0 | 16,063 | 14.4 K to 16.1 K (+11.24 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 10,000 | 86,667 | 186,628 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 0.00 | 4,868 | 0 | 29,206 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 250.61 | 10,000 | 2,506,121 | 475,042 | 485 K to 475 K (-2.06 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 10,000 | 86,667 | 485,042 | 475 K to 485 K (+2.11 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 0.00 | 4,868 | 0 | 475,042 | 470.2 K to 475 K (+1.04 %) |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Option Exercise | M | 0.00 | 649 | 0 | 3,894 | |
| Jul 03 2014 | ICPT | INTERCEPT PHARMACE ... | Adorini Luciano | Chief Scientific Of ... | Buy | M | 0.00 | 649 | 0 | 8,113 | 7.5 K to 8.1 K (+8.70 %) |